January 23, 2017
The Ministry of Health, Labor and Welfare (MHLW) is increasingly confident that counterfeits of Gilead Sciences’ hepatitis C treatment Harvoni (ledipasvir + sofosbuvir), which were discovered in a pharmacy chain in Nara Prefecture, entered the supply chain prior to their...read more